Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 5, 2009, Pages 582-587

  Domingo, Pere ^a   Suarez Lozano, Ignacio ^b   Torres, Ferran ^c   Pomar, Virginia ^a   Ribera, Esteban ^d   Galindo, Ma Jose ^e   Cosin, Jaime ^f   Garcia Alcalde, Ma Luisa ^g   Vidal, Francesc ^h   Lopez Aldeguer, Jose ⁱ   Roca, Bernardino ^j   Gonzalez, Juan ^k   Lozano, Fernando ^l   Garrido, Myriam ^m  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL INFANTA ELENA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL DE CABUEÑES   (Spain)

^h HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^j HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^k HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^l HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^m Data Management VACH Group   (Spain)

more..

Author keywords

Bacterial meningitis; HIV 1 infection; Pneumococcal disease; Pneumococcal vaccine; Prognosis; Streptococcus pneumoniae

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCOMPROMISED PATIENT; INCIDENCE; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE RIGIDITY; NEISSERIA MENINGITIDIS; NEUROLOGICAL COMPLICATION; NUCHAL RIGIDITY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEIZURE; SPAIN; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MENINGITIS, BACTERIAL; MENINGITIS, LISTERIA; MENINGITIS, MENINGOCOCCAL; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 68449090642     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181adcb01     Document Type: Article

References (19)

1. Schlech WF, Ward JI, Band JD, et al. Bacterial meningitis in the United States, 1978 through 1981: the national bacterial meningitis surveillance study. JAMA. 1985;253:1749-1754.
2. van de Beek D, de Gans J, Tunkel AR, et al. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354:44-53.
3. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849-1859.
4. de Almeida S, Savalla G, Mendez B, et al. Acute bacterial meningitis in HIV patients in southern Brazil. Arq Neuropsiquiatr. 2007;65:273-278.
5. Almirante B, Saballs M, Ribera E, et al. Favorable prognosis of bacterial meningitis in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1998;27:176-180.
6. Domingo P, Suarez-Lozano I, Teira R, et al. Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH Cohort. Open AIDS J. 2008;2:8-20.
7. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Twelve Informational Supplement M102-S12. Wayne, PA: NCCLS; 2002.
8. Domingo P, Barquet N, Alvarez M, et al. Group B streptococcal meningitis in adults. Report of twelve cases and review. Clin Infect Dis. 1997;25:1180-1187.
9. Fauci AS, Pantaleo G, Stanley S, et al. Immunopathogenic mechanisms of HIV infection. Ann Intern Med. 1996;124:654-663.
10. Lane HC, Depper JM, Greene WC, et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985;313:79-84.
11. Gordon SB, Chaponda M, Walsh AL, et al. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS. 2002;16:1409-1417.
12. Scarborough M, Gordon SB, Whitty CJ, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med. 2007;357:2507-2509.
13. Grau I, Pallares R, Tubau F, et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med. 2005;165:1533-1540.
14. Heffernan RT, Barrett NL, Gallagher KM, et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis. 2005;191:2038-2045.
15. Jordano Q, Falco V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis. 2004;38:1623-1628.
16. Barry PM, Zetola N, Keruly JC, et al. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003. AIDS. 2006;20:437-444.
17. Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis. 2007;20:11-15.
18. Peñaranda M, Falcó V, Payeras A, et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin Infect Dis. 2007;45:e82-e87.
19. Watera C, Nakiyingi J, Miiro G, et al. 23-valent pneumococcal polysaccharide vaccine in HIV infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS. 2004;18:1210-1213.